NYSE · PHARMACEUTICAL PREPARATIONS · SMALL CAP
ADC Therapeutics SA ADCT
4 fiscal years on record · USD · FY2025 reported · SEC filings only
In brief
What this company does
Written from the business description in ADC Therapeutics SA's annual report to the U.S. Securities and Exchange Commission, filed 10 March 2026. Every sentence was checked against that document before publication.
Growth
USD 81.4M
Revenue, FY2025 · full 4-year series below
Revenue $M
Net income $M
FY2025 · Revenue 81.4 · Net income -142.6
Compound annual growth
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
−175 cents
lost on every revenue dollar
Operating margin
Net margin
FY2025 · Operating -149.3% · Net -175.3%
ROE
Not applicable: equity was negative in this period, so return on equity has no meaning.
The 4-year record
4 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue $B | 0.1 | 0.1 | 0.1 | 0.1 |
| Operating income $B | −0.1 | −0.1 | −0.2 | −0.1 |
| EBITDA $B | −0.1 | −0.1 | −0.2 | −0.1 |
| Income tax $B | 0.0 | 0.0 | 0.0 | 0.0 |
| Net income $B | −0.1 | −0.2 | −0.2 | −0.2 |
| Free cash flow $B | −0.1 | −0.1 | −0.1 | −0.1 |
| EPS, diluted $ | −1.12 | −1.62 | −2.94 | −2.01 |
| Dividend / sh $ | · | · | · | · |
| Payout % | · | · | · | · |
| ROE % | · | · | · | −134.6 |
| Shares out B | 0.13 | 0.10 | 0.08 | 0.08 |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 17 reconciliationsAUDITED
Reconciled in 5 of 19 fiscal years. 74 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityPharmaceutical Preparations
Listed onNYSE
Incorporated inoutside the United States — SEC code V8
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2021